Simple jQuery Dropdowns

Browsing by Author Novartis Pharmaceuticals

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)
1-Jan-2014Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: The safety profile of deferasiroxAli T. Taher; John B. Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Raffaella Origa; Zeynep Karakas; Dany Habr; Zewen Zhu; M. Domenica Cappellini; American University of Beirut; UCL; Mahidol University; University of Athens; King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University; Ospedale Regional Microcitemie; Istanbul Tip Fakultesi; Novartis Pharmaceuticals; Universita degli Studi di Milano
1-Jun-2018Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysisFrank Kloprogge; Lesley Workman; Steffen Borrmann; Mamadou Tékété; Gilbert Lefèvre; Kamal Hamed; Patrice Piola; Johan Ursing; Poul Erik Kofoed; Andreas Mårtensson; Billy Ngasala; Anders Björkman; Michael Ashton; Sofia Friberg Hietala; Francesca Aweeka; Sunil Parikh; Leah Mwai; Timothy M.E. Davis; Harin Karunajeewa; Sam Salman; Francesco Checchi; Carole Fogg; Paul N. Newton; Mayfong Mayxay; Philippe Deloron; Jean François Faucher; François Nosten; Elizabeth A. Ashley; Rose McGready; Michele van Vugt; Stephane Proux; Ric N. Price; Juntra Karbwang; Farkad Ezzet; Rajesh Bakshi; Kasia Stepniewska; Nicholas J. White; Philippe J. Guerin; Karen I. Barnes; Joel Tarning; Pharmetheus AB; Muhimbili University of Health and Allied Sciences; Bandim Health Project; Institut Pasteur du Cambodge; Kenya Medical Research Institute; Shoklo Malaria Research Unit; University of Western Australia; London School of Hygiene & Tropical Medicine; Universite Paris Descartes; Walter and Eliza Hall Institute of Medical Research; University of Oxford; Danderyd Hospital; Menzies School of Health Research; University of Portsmouth; University of California, San Francisco; Centre de Recherches Pour Le Développement International; UCL; Karolinska University Hospital; Universität Tübingen; Göteborgs Universitet; CHU de Limoges; Epicentre; Mahidol University; Karolinska Institutet; Nagasaki University; Novartis International AG; Yale University; Charles Darwin University; Uppsala Universitet; Amsterdam UMC - University of Amsterdam; University of Cape Town; Kolding Sygehus; WorldWide Antimalarial Resistance Network; University of Sciences; Novartis Pharmaceuticals; Wellcome Trust Research Unit; WorldWide Antimalarial Resistance Network; Myanmar Oxford Clinical Research Unit; World Wide Antimalarial Resistance Network (WWARN)-Asia Regional Centre; WorldWide Antimalarial Resistance Network; Afya Research Africa; University of Health Sciences
1-Jan-2011Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadDudley J. Pennell; John B. Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi Kong Li; Vip Viprakasit; Mohsen Saleh Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher; Royal Brompton Hospital; UCL; Universita degli Studi di Milano; University of Malaya Medical Centre; Cairo University; Ege University Medical School; Kuala Lumpur Hospital; Prince of Wales Hospital Hong Kong; Mahidol University; Ain Shams University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; American University of Beirut
1-Jun-2013Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patientsAli T. Taher; John B. Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Dany Habr; Jacqueline Ros; Yiyun Zhang; M. Domenica Cappellini; American University of Beirut Medical Center; UCL Cancer Institute; Mahidol University; University of Athens; Chulalongkorn University; Ospedale Regional Microcitemie; Istanbul Tip Fakultesi; Novartis International AG; Novartis Pharmaceuticals; Universita degli Studi di Milano
1-Nov-2013Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA studyAli T. Taher; John B. Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Dany Habr; Jacqueline Ros; Zewen Zhu; M. Domenica Cappellini; American University of Beirut; UCL; Mahidol University; University of Athens; Chulalongkorn University; Universita degli Studi di Cagliari; Istanbul Tip Fakultesi; Novartis International AG; Novartis Pharmaceuticals; Universita degli Studi di Milano
1-Jun-2012Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia majorDudley J. Pennell; John B. Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi Kong Li; Vip Viprakasit; Mohsen S. Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher; Royal Brompton Hospital; UCL; Universita degli Studi di Milano; University of Malaya Medical Centre; Cairo University; Ege Universitesi; Kuala Lumpur Hospital; Prince of Wales Hospital Hong Kong; Mahidol University; Ain Shams University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; American University of Beirut
1-Sep-2010Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC studyNorbert Gattermann; Carlo Finelli; Matteo Della Porta; Pierre Fenaux; Arnold Ganser; Agnes Guerci-Bresler; Mathias Schmid; Kerry Taylor; Dominique Vassilieff; Dany Habr; Gabor Domokos; Bernard Roubert; Christian Rose; L. Agaoglu; G. Alimena; D. Alonso; S. Ame; E. Angelucci; B. Arrizabalaga; M. Athanasiou-Metaxa; B. Augustson; Y. Aydinok; A. Baba; M. Baccarani; J. Beck; P. Beris; O. Beyne-Rauzy; H. Birgens; D. Bordessoule; C. Borgna-Pignatti; A. Bosly; K. Bouabdallah; D. Bowden; D. Bowen; D. Bron; M. D. Cappellini; M. Capra; G. Cartron; M. Cazzola; C. Chalkias; L. L. Chan; S. Chancharunee; C. Chapman; P. Charoenkwan; E. Chasapopoulou; S. Cheze; A. Chuansumrit; P. Cianciulli; C. Dauriac; M. Delforge; G. Dölken; H. Dombret; J. Duyster; T. Economopoulos; G. Ehninger; M. Elalfy; A. El-Beshlawy; L. Enggaard; G. Fillet; A. Filosa; G. Forni; R. Galanello; G. Gastl; S. Giraudier; A. Goldfarb; A. Grigg; F. Gumruk; S. Y. Ha; D. Haase; B. Heinrich; M. Hertzberg; J. Ho; H. C. Hsu; S. Huang; M. Hunault-Berger; B. Inusa; D. Jaulmes; J. Jensen; A. Kattamis; Y. Kilinc; K. H. Kim; S. Kinsey; L. Kjeldsen; A. Koren; M. E. Lai; Y. Lai; J. W. Lee; K. H. Lee; S. H. Lee; L. Legros; C. Li; C. K. Li; Q. Li; K. H. Lin; W. Linkesch; M. Lübbert; D. Lutz; A. J. Mohamed Thalha; G. Mufti; P. Muus; Heinrich Heine Universitat; Alma Mater Studiorum Universita di Bologna; Universita degli Studi di Pavia; Hopital Avicenne; Medizinische Hochschule Hannover (MHH); Hopital Brabois Adultes; Universitatsklinikum Ulm; Mater Hospital; Universite Paris Descartes; Novartis Pharmaceuticals; Novartis International AG; Hopital Saint Vincent-de-Paul GHICL; Istanbul Universitesi; Azienda Policlinico Umberto I; Hospital Universitario Virgen del Rocio; Hopital de Hautepierre; Azienda Ospedaliera Brotzu - Businco; Hospital de Cruzes; Aristotle University of Thessaloniki; Sir Charles Gairdner Hospital; Ege Universitesi; Hospital Universiti Sains Malaysia; Osp. Bologna; Klinikum der Johannes-Gutenberg-Universitat und Fachbereich Medizin; Hopitaux universitaires de Geneve; Hopital Purpan; Amtssygehusetl Herlev; CHU de Limoges; Az. Ospedaliera Universitaria St. Anna; Cliniques Universitaires UCL; CHU Hopitaux de Bordeaux; Monash Medical Centre; Leeds General Infirmary; Institut Jules Bordet; Universita degli Studi di Milano; Ospedale Civico M. Ascoli; Clinique Victor Hugo; Fondazione IRCCS Policlinico San Matteo; Larissa General Hospital; University of Malaya Medical Centre; Mahidol University; Leicester Royal Infirmary; Chiang Mai University; University Hospitalof Thessaloniki AHEPA; Hopital Clemenceau; Ospedale S. Eugenio; Hopital Pontchaillou; KU Leuven– University Hospital Leuven; Ernst-Moritz-Arndt-Universitat Greifswald; Hopital Saint-Louis; Technical University of Munich; University of Athens Medical School; Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus; Ain Shams University; Cairo University; Hillerod Hospital; Centre Hospitalier Universitaire de Liege; Azienda Ospedaliera Di Rilievo Nazionale Antonio Cardarelli; E.O. Ospedali Galliera; Azienda Ospedaliera Brotzu - Microcitemico; Medizinische Universitat Innsbruck; Hopital Henri Mondor; Hadassah University Medical Centre; Royal Melbourne Hospital; Hacettepe Universitesi; Queen Mary Hospital Hong Kong; Universitatsmedizin Gottingen; Gemeinschaftspraxis Brudler/ Heinrich; Westmead Hospital; Royal Prince Alfred Hospital; Veterans General Hospital-Taipei; Guang Zhou Zhong Shan No.2 Hospital; CHU Angers; Evelina Children's Hospital; Hopital Saint-Antoine; Aarhus Amtssygehus, Aarhus University Hospital; University of Athens; Cukurova Universitesi; Samsung Medical Center, Sungkyunkwan University; St James's University Hospital; Rigshospitalet; Emek Medical Center; Hospital of Nanjing Medical University; The Catholic University of Korea; Asan Medical Center; Royal Adelaide Hospital; Centre Hospitalier Universitaire de Nice, Hopital l'Archet; Nanfang Hospital; Prince of Wales Hospital Hong Kong; Branch of Shanghai No.1 Hospital; National Taiwan University Hospital; LKH-Universitatsklinikum Graz; Universitats Klinikum Freiburg und Medizinische Fakultat; A. Ö. Krankenhausder Elisabethinen; Hospital Universiti Kebangsaan Malaysia; King's College Hospital NHS Foundation Trust; Radboud University Nijmegen Medical Centre
2-Aug-2012Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-Year results from a prospective, randomized, double-blind, placebo-controlled studyAli T. Taher; John Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Jacqueline Ros; Yiyun Zhang; Dany Habr; Maria Domenica Cappellini; American University of Beirut; UCL; Mahidol University; University of Athens; Chulalongkorn University; Universita degli Studi di Cagliari; Istanbul Tip Fakultesi; Novartis International AG; Novartis Pharmaceuticals; Universita degli Studi di Milano
18-Jun-2015Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overloadYesim Aydinok; Antonis Kattamis; M. Domenica Cappellini; Amal El-Beshlawy; Raffaella Origa; Mohsen Elalfy; Yurdanur Kilinç; Silverio Perrotta; Zeynep Karakas; Vip Viprakasit; Dany Habr; Niculae Constantinovici; Junwu Shen; John B. Porter; Ege University Medical School; University of Athens; Universita degli Studi di Milano; Cairo University; Universita degli Studi di Cagliari; Ain Shams University; Cukurova Universitesi; Child and of General and Specialist Surgery; Istanbul Tip Fakultesi; Mahidol University; Novartis Pharmaceuticals; Novartis International AG; UCL Cancer Institute
18-Jan-2013Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemiasVip Viprakasit; Norbert Gattermann; Jong Wook Lee; John B. Porter; Ali T. Taher; Dany Habr; Nicolas Martin; Gabor Domokos; Maria Domenica Cappellini; Mahidol University; Heinrich Heine Universitat; The Catholic University of Korea; UCL; American University of Beirut; Novartis Pharmaceuticals; Novartis International AG; Universita degli Studi di Milano
17-Jun-2010Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemiaGiuseppe Saglio; Dong Wook Kim; Surapol Issaragrisil; Philipp Le Coutre; Gabriel Etienne; Clarisse Lobo; Ricardo Pasquini; Richard E. Clark; Andreas Hochhaus; Timothy P. Hughes; Neil Gallagher; Albert Hoenekopp; Mei Dong; Ariful Haque; Richard A. Larson; Hagop M. Kantarjian; Universita degli Studi di Torino; The Catholic University of Korea; Mahidol University; Charité – Universitätsmedizin Berlin; Institut Bergonie; Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti; Universidade Federal do Parana; Royal Liverpool and Broadgreen University Hospitals NHS Trust; Universitatsklinikum Jena und Medizinische Fakultat; Royal Adelaide Hospital; Novartis International AG; Novartis Pharmaceuticals; University of Chicago; University of Texas MD Anderson Cancer Center
1-Mar-2016Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS studyAli T. Taher; M. Domenica Cappellini; Yesim Aydinok; John B. Porter; Zeynep Karakas; Vip Viprakasit; Noppadol Siritanaratkul; Antonis Kattamis; Candace Wang; Zewen Zhu; Victor Joaquin; Marie José Uwamahoro; Yong Rong Lai; American University of Beirut Medical Center; Università degli Studi di Milano; Ege University Medical School; UCL; Istanbul Tip Fakultesi; Mahidol University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; Guangxi Medical University
1-Dec-2018Transcriptomic analysis reveals reduced transcriptional activity in the malaria parasite Plasmodium cynomolgi during progression into dormancyNicole L. Bertschi; Annemarie Voorberg-Van der Wel; Anne Marie Zeeman; Sven Schuierer; Florian Nigsch; Walter Carbone; Judith Knehr; Devendra K. Gupta; Sam O. Hofman; Nicole van der Werff; Ivonne Nieuwenhuis; Els Klooster; Bart W. Faber; Erika L. Flannery; Sebastian A. Mikolajczak; Vorada Chuenchob; Binesh Shrestha; Martin Beibel; Tewis Bouwmeester; Niwat Kangwanrangsan; Jetsumon Sattabongkot; Thierry T. Diagana; Clemens H.M. Kocken; Guglielmo Roma; Biomedical Primate Research Centre - Rijswijk; Mahidol University; Novartis International AG; Novartis Pharmaceuticals